Open AccessCombined use of radioiodine therapy and radiofrequency ablation in treating postsurgical thyroid remnant of differentiated thyroid carcinoma
Author(s) -
Bin Lü,
Linfa Li,
Lifang Yao,
Shoucong Chen,
Heqing Yi,
Xuemei Ye,
Dong Xu,
Peng Wu
Publication year - 2015
Publication title -
journal of cancer research and therapeutics/journal of cancer research and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 0973-1482
pISSN - 1998-4138
DOI - 10.4103/0973-1482.170530
Subject(s) - medicine , radiofrequency ablation , thyroid , thyroid carcinoma , ablation , thyroidectomy , wilcoxon signed rank test , thyroid cancer , hormone , urology , nuclear medicine , mann–whitney u test
To determine whether postoperative radioiodine (RAI) combined with radiofrequency ablation (RFA) is an effective, safe, and feasible method for elimination of excessive postsurgical thyroid remnant for differentiated thyroid carcinoma (DTC).